Crilly J. The history of clozapine and its emergence in the US market: a review and analysis. Hist Psychiatry. 2007;18:39–60.

Article  PubMed  Google Scholar 

Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Am J Psychiatry. 2001;158:518–26.

Article  CAS  PubMed  Google Scholar 

Tiihonen J, Lönnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, et al. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet. 2009;374:620–7.

Article  PubMed  Google Scholar 

de Leon J, Ruan C-J, Schoretsanitis G, De las Cuevas C. A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology. Psychother Psychosom. 2020;89:200–14.

Article  PubMed  Google Scholar 

Cooper LT. Myocarditis. N Engl J Med. 2009;360:1526–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Remington G, Lee J, Agid O, Takeuchi H, Foussias G, Hahn M, et al. Clozapine’s critical role in treatment resistant schizophrenia: ensuring both safety and use. Expert Opin Drug Saf. 2016;15:1193–203.

Article  CAS  PubMed  Google Scholar 

Bellissima BL, Tingle MD, Cicović A, Alawami M, Kenedi C. A systematic review of clozapine-induced myocarditis. Int J Cardiol. 2018;259:122–9.

Article  PubMed  Google Scholar 

Vaziri N, Marques D, Greenway SC, Bousman CA. The cellular mechanism of antipsychotic-induced myocarditis: a systematic review. Schizophr Res. 2023;261:206–15.

Article  PubMed  Google Scholar 

Bousman C, Greenway SC, Tarailo-Graovac M, Long Q, Sellmer R, Crockford D, et al. editors. The pharmacogenomics of clozapine-induced myocarditis (PROCLAIM) consortium. Neuropsychopharmacology. 2018: Nature publishing group macmillan building, 4, England.

Ronaldson KJ, Fitzgerald PB, Taylor AJ, Topliss DJ, McNeil JJ. A new monitoring protocol for clozapine-induced myocarditis based on an analysis of 75 cases and 94 controls. Aust N Z J Psychiatry. 2011;45:458–65.

Article  PubMed  Google Scholar 

Churko JM, Burridge PW, Wu JC. Generation of human iPSCs from human peripheral blood mononuclear cells using non-integrative Sendai virus in chemically defined conditions. Methods Mol Biol. 2013;1036:81–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vaziri N, Marques D, Wang X, Machiraju P, Narang A, Vlahos K, et al. Generation of two human induced pluripotent stem cell lines from peripheral blood mononuclear cells of clozapine-tolerant and clozapine-induced myocarditis patients with treatment-resistant schizophrenia. Stem Cell Res. 2022;63:102877.

Article  CAS  PubMed  Google Scholar 

Machiraju P, Huang J, Iqbal F, Liu Y, Wang X, Bousman C, et al. Early inhibition of retinoic acid signaling rapidly generates cardiomyocytes expressing ventricular markers from human induced pluripotent stem cells. bioRxiv. 2019:856575.

Zhang Q, Jiang J, Han P, Yuan Q, Zhang J, Zhang X, et al. Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals. Cell Res. 2011;21:579–87.

Article  CAS  PubMed  Google Scholar 

Titier K, Canal M, Déridet E, Abouelfath A, Gromb S, Molimard M, et al. Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice. Toxicol Appl Pharmacol. 2004;199:52–60.

Article  CAS  PubMed  Google Scholar 

Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry. 2018;51:9–62.

Article  CAS  PubMed  Google Scholar 

Wu J, Hao S, Sun X-R, Zhang H, Li H, Zhao H, et al. Elamipretide (SS-31) ameliorates isoflurane-induced long-term impairments of mitochondrial morphogenesis and cognition in developing rats. Front Cell Neurosci. 2017;11:119.

Article  PubMed  PubMed Central  Google Scholar 

Chavez JD, Tang X, Campbell MD, Reyes G, Kramer PA, Stuppard R, et al. Mitochondrial protein interaction landscape of SS-31. Proc Natl Acad Sci. 2020;117:15363–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Szeto HH. First‐in‐class cardiolipin‐protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol. 2014;171:2029–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Machiraju P, Wang X, Sabouny R, Huang J, Zhao T, Iqbal F, et al. SS-31 peptide reverses the mitochondrial fragmentation present in fibroblasts from patients with DCMA, a mitochondrial cardiomyopathy. Front Cardiovasc Med. 2019;6:167.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rohani L, Machiraju P, Sabouny R, Meng G, Liu S, Zhao T, et al. Reversible mitochondrial fragmentation in iPSC-derived cardiomyocytes from children with DCMA, a mitochondrial cardiomyopathy. Can J Cardiol. 2020;36:554–63.

Article  PubMed  Google Scholar 

Chetwood J, Gupta S, Subramaniam K, De Cruz P, Moore G, An Y, et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis–national extended follow-up and a review of the literature. Expert Opin Drug Saf. 2024;23:449–56.

Article  CAS  PubMed  Google Scholar 

Gorski KS, Waller EL, Bjornton-Severson J, Hanten JA, Riter CL, Kieper WC, et al. Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists. Int Immunol. 2006;18:1115–26.

Article  CAS  PubMed  Google Scholar 

Sala L, Van Meer BJ, Tertoolen LG, Bakkers J, Bellin M, Davis RP, et al. MUSCLEMOTION: a versatile open software tool to quantify cardiomyocyte and cardiac muscle contraction in vitro and in vivo. Circ Res. 2018;122:e5–e16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998;273:32608–13.

Article  CAS  PubMed  Google Scholar 

Zhang F, Han L, Wang J, Shu M, Liu K, Zhang Y, et al. Clozapine induced developmental and cardiac toxicity on Zebrafish Embryos by elevating oxidative stress. Cardiovasc Toxicol. 2021;21:399–409.

Article  PubMed  Google Scholar 

Abdel-Wahab BA, Metwally ME. Clozapine-induced cardiotoxicity in rats: involvement of tumour necrosis factor alpha, NF-κβ and caspase-3. Toxicol Rep. 2014;1:1213–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdel-Wahab BA, Metwally ME. Clozapine-induced cardiotoxicity: role of oxidative stress, tumour necrosis factor alpha and NF-κβ. Cardiovasc Toxicol. 2015;15:355–65.

Article  CAS  PubMed  Google Scholar 

Hayes RD, Downs J, Chang C-K, Jackson RG, Shetty H, Broadbent M, et al. The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders. Schizophr Bull. 2015;41:644–55.

Article  PubMed  Google Scholar 

Yusufi B, Mukherjee S, Flanagan R, Paton C, Dunn G, Page E, et al. Prevalence and nature of side effects during clozapine maintenance treatment and the relationship with clozapine dose and plasma concentration. Int Clin Psychopharmacol. 2007;22:238–43.

Article  PubMed  Google Scholar 

Nilsson BM, Edström O, Lindström L, Wernegren P, Bodén R. Tachycardia in patients treated with clozapine versus antipsychotic long-acting injections. Int Clin Psychopharmacol. 2017;32:219–24.

Article  PubMed  PubMed Central  Google Scholar 

Kawano H, Okada R, Kawano Y, Sueyoshi N, Shirai T. Apoptosis in acute and chronic myocarditis. Jpn Heart J. 1994;35:745–50.

Article  CAS  PubMed  Google Scholar